Sign in to continue:

Monday, July 27th, 2026

金宇生物技术股份有限公司股东股份质押公告及最新质押情况披露

金宇生物技术股份有限公司股东股份质押公告详解

金宇生物技术股份有限公司:股东股份质押公告详解

要点概述

  • 内蒙古金宇生物控股有限公司(以下简称“生物控股”)于2026年5月11日,将其持有的2,450,000股金宇生物技术股份有限公司(以下简称“公司”)无限售流通股质押给浙商证券股份有限公司。
  • 本次质押股份数占生物控股持有公司股份的1.95%,占公司总股本的0.22%。
  • 本次质押后,生物控股累计质押公司股份18,270,000股,占其所持公司股份的14.56%,占公司总股本的1.64%。
  • 本次质押主要用于融资周转,未涉及重大资产重组业绩补偿等担保事项。
  • 公司董事会声明,本次质押不会导致公司控制权变更,也不会影响公司生产经营和治理结构。

详细内容

1. 股东股份质押基本情况

生物控股本次质押股份为2,450,000股,全部为无限售流通股,无补充质押安排。质押起始日为2026年5月11日,到期日为2027年5月11日,质权人为浙商证券股份有限公司。质押股份占生物控股持股比例为1.95%,占公司总股本0.22%。本次质押所获资金主要用于融资周转。

2. 股东累计质押情况

截至公告披露日,生物控股持有公司股份125,510,800股,占公司总股本的11.29%。本次质押完成后,累计质押股份18,270,000股,占持股比例14.56%,占公司总股本1.64%。其他一致行动人张翀宇、张竞均无质押股份。

股东名称 持股数量(股) 持股比例(%) 本次质押前累计质押数量(股) 本次质押后累计质押数量(股) 占其所持股份比例(%) 占公司总股本比例(%)
内蒙古金宇生物控股有限公司 125,510,800 11.29 15,820,000 18,270,000 14.56 1.64
张翀宇 23,003,826 2.07 0 0 0 0
张竞 6,132,742 0.55 0 0 0 0

3. 对公司控制权与经营的影响

公告明确指出,本次股份质押不会导致公司实际控制权发生变更,不会对公司生产经营和公司治理产生影响。生物控股及其一致行动人资信状况良好,具备充足的风险控制能力。如后续出现平仓风险,将采取补充质押或补充保证金等措施应对。如果相关质押事项发生其他重大变动,公司将依法披露。

股东与投资人关注事项

  • 本次股份质押金额较小,占公司总股本比例仅为0.22%,但累计质押比例有所提升,达到持股的14.56%。若未来大股东质押比例继续提升,可能引发市场对公司股权稳定性的关注。
  • 目前质押主要用于融资周转,未涉及重大资产重组或业绩补偿等敏感用途,短期内对公司股价影响有限。
  • 若后续出现股价波动导致平仓风险,控股股东需及时补充质押或保证金,否则可能影响公司股价及投资者信心。

结论

本次公告显示,控股股东质押比例有所增加,但整体质押风险可控,对公司经营及控制权暂无明显影响。投资者可持续关注后续质押比例变动及潜在平仓风险。


免责声明:本文内容基于公司公告整理,仅供投资者参考,不构成投资建议。投资有风险,入市需谨慎。


English Version
Detailed Analysis of Jinyu Bio-technology Shareholder Pledge Announcement

Jinyu Bio-technology Co., Ltd.: In-depth Analysis of Shareholder Share Pledge Announcement

Key Highlights

  • Inner Mongolia Jinyu Biological Holdings Co., Ltd. (“Jinyu Holdings”) on May 11, 2026, pledged 2,450,000 unrestricted tradable shares of Jinyu Bio-technology Co., Ltd. (“the Company”) to Zheshang Securities Co., Ltd.
  • This pledged amount accounts for 1.95% of Jinyu Holdings’ total holdings and 0.22% of the Company’s total share capital.
  • After this pledge, Jinyu Holdings’ cumulative pledged shares reach 18,270,000, representing 14.56% of its shareholdings and 1.64% of the Company’s total share capital.
  • The pledge is mainly for liquidity purposes and does not involve performance compensation for major asset restructuring or any other guarantee purposes.
  • The Board assures that this pledge will not cause any change of control or impact the Company’s operations or governance.

Detailed Information

1. Basic Information of the Share Pledge

Jinyu Holdings pledged 2,450,000 unrestricted tradable shares, with no supplementary pledge arrangement. The pledge period is from May 11, 2026, to May 11, 2027. The pledgee is Zheshang Securities Co., Ltd. The pledged shares represent 1.95% of the shareholder’s stake and 0.22% of the Company’s total share capital. Funds raised are for liquidity purposes.

2. Cumulative Shareholder Pledge Situation

As of the disclosure date, Jinyu Holdings holds 125,510,800 shares (11.29% of the Company’s total share capital). After this pledge, cumulative pledged shares total 18,270,000 (14.56% of its shareholdings, 1.64% of the total share capital). Other concerted parties, Zhang Chongyu and Zhang Jing, have no pledged shares.

Shareholder Shares Held Shareholding Ratio (%) Cumulative Pledged Shares Before Cumulative Pledged Shares After Pledged/Shareholding (%) Pledged/Total Share Capital (%)
Inner Mongolia Jinyu Holdings 125,510,800 11.29 15,820,000 18,270,000 14.56 1.64
Zhang Chongyu 23,003,826 2.07 0 0 0 0
Zhang Jing 6,132,742 0.55 0 0 0 0

3. Impact on Control and Operations

The announcement clearly states that this pledge will not lead to any change in actual control, nor will it affect the Company’s operations or governance. Jinyu Holdings and its concerted parties have good creditworthiness and adequate risk control capabilities. Should there be forced liquidation risk, they will provide additional pledges or margin. Any significant changes in the pledge will be disclosed in a timely manner.

Key Takeaways for Shareholders and Investors

  • Although the pledged amount is relatively small (0.22% of total share capital), the cumulative pledge rate rises to 14.56% of the major shareholder’s holding. If the pledge rate further increases, market concerns about shareholding stability could emerge.
  • The current pledge is for liquidity and not for sensitive uses like major asset restructuring or performance compensation. Short-term price impact may be limited.
  • If future share price volatility triggers forced liquidation risk, the controlling shareholder must provide supplementary pledges or margin, or there could be an impact on the share price and investor confidence.

Conclusion

The announcement indicates a moderate increase in the controlling shareholder’s pledge rate, but overall risk appears manageable with no current impact on control or operations. Investors should continue to monitor future changes in the pledge ratio and potential forced liquidation risk.


Disclaimer: This article is compiled from company announcements for reference only and does not constitute investment advice. Please invest cautiously.


View 生物股份 Historical chart here



东睦股份发行股份及支付现金购买资产并募集配套资金暨关联交易最新进展公告

核心要点 重大资产重组方案:公司拟通过发行股份及支付现金方式,向钟伟、上海创精投资咨询合伙企...

海南矿业2024年限制性股票激励计划部分限制性股票回购注销实施公告

海南矿业股份有限公司2024年限制性股票回购注销实施公告深度解读 海南矿业股份有限公司2024年限制性股票激励计划部...

云南城投置业股份有限公司重大资产重组最新进展公告(2026年4月)

云南城投置业股份有限公司重大资产重组进展公告详解 报告关键要点 截至2026年4月17日,云南城投置业股份有限公司(证...